The Effect of Dutasteride on Serum Prostate-specific Antigen (PSA) in Patients with Benign Prostate Hypertrophy.
Gil Ho Lee, Joo Hyung Hong, Hyung Jee Kim
J Korean Continence Soc. 2008;12(1):42-47.   Published online 2008 Jun 30
Citations to this article as recorded by
  Crossref logo
Treatment options for benign prostate enlargement
Deidre Vlotman-Novinuk
Journal of Prescribing Practice.2019; 1(3): 130.     CrossRef
Superiority of dutasteride 0.5 mg and tamsulosin 0.2 mg for the treatment of moderate‐to‐severe benign prostatic hyperplasia in Asian men
Nazneen Haque, Naoya Masumori, Sadaaki Sakamoto, Zhangqun Ye, Sang‐Jin Yoon, Hann‐Chorng Kuo, Betsy Brotherton, Timothy Wilson, Chandra Muganurmath, Megan McLaughlin, Michael Manyak
International Journal of Urology.2018; 25(11): 944.     CrossRef
Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy
Sung Woon Park, Chul Sung Kim, Gilho Lee
Korean Journal of Urology.2010; 51(12): 824.     CrossRef